There is no commercial support for this activity.

About This Speaker

Dr. Zisook is a Distinguished Professor of Psychiatry UC San Diego. He directs the UC San Diego Healer Education, Assessment and Referral (HEAR) program, dedicated to preventing/reducing nurse and physician mental health stigma, burnout, and suicide. He serves on the Scientific Review Board and Grant Review Committee of the American Foundation for Suicide Prevention (AFSP), Scientific Advisory Board of the Depression and Bipolar Support Alliance (DBSA), Board of Directors of the American College of Psychiatry and the Board of Directors of the American Society of Clinical Pharmacology. He is the UC San Diego PI on an industry-sponsored multi-site study assessing Psilocybin assisted psychotherapy for treatment resistant depression. Academic interests include treatment resistant depression, suicide prevention with a special interest in physician suicide prevention, grief and bereavement, and psychiatric education. 

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling,  re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Sidney Zisook, MD, reports a financial relationship with COMPASS Ltd., as a researcher during the past 12 months.  He will not discuss products, services or off label uses in this presentation. This presentation was initially planned and recorded prior to January 1, 2023; therefore, the financial disclosure statement from the speaker reflects only the preceding 12 months, as was the standard at the time. This enduring activity was last reviewed for content validity on September 29, 2023. All conflicts have been mitigated through review.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Deepak Prabhakar, MD, Elizabeth Ryznar, MD, MSc, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Stacey Garnett, RN, MSN, Stephanie M. Robinson, MSN, RN, PMH-BC, NPD-BC, NE-BC , Heather Billings, RN, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.